Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
β Scribed by Tomoki Origuchi; Naoki Iwamoto; Shin-ya Kawashiri; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Kazuhiko Arima; Hideki Nakamura; Satoshi Yamasaki; Hiroaki Ida; Atsushi Kawakami; Yukitaka Ueki; Naoki Matsuoka; Munetoshi Nakashima; Akinari Mizokami; Yojiro Kawabe; Masanobu Mine; Takaaki Fukuda; Katsumi Eguchi
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 334 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1439-7595
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate whether circulating levels of soluble tumor necrosis factor receptors (sTNFR) are predictive of mortality in rheumatoid arthritis (RA). ## Methods Levels of sTNFRI and sTNFRII at study entry were quantified using enzymeβlinked immunosorbent assays in sera